Klaus Puel, Wolfgang Pieken, Daniel Kisner, David Milligan, Wally Parce, Robert Booth | GenomeWeb

Klaus Puel has been appointed CEO and president of oligo and DNA synthesis reagent supplier Proligo, a Boulder, Colo., subsidiary of German company Degussa. Puel replaces Proligo co-founder Wolfgang Pieken, who has stepped down to pursue other business interests, the company said.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.